ORIGINAL RESEARCH

Human enteroviruses exhibit selective oncolytic activity in the model of human glioblastoma multiforme xenografts in immunodeficient mice

About authors

1 Engelhardt Institute of Molecular Biology, Moscow, Russia

2 Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow

3 Pirogov Russian National Research Medical University, Moscow, Russia

4 N. N. Blokhin Russian Cancer Research Center, Moscow, Russia

Correspondence should be addressed: Peter M. Chumakov
ul. Vavilova, 32, Moscow, 119991; moc.oohay@mpvokamuhc

About paper

Funding: the study was supported by the Ministry of Education and Science of the Russian Federation; project code RFMEFI60714X0014.

Received: 2018-06-26 Accepted: 2018-06-30 Published online: 2018-07-13
|
Fig. 1. Sensitivity of early-passage monolayer cell cultures obtained from two glioblastoma patients to four strains oncolytic enteroviruses: —○— — Type 1 Poliovirus; --∆-- — Coxsackie virus A7; —□— — Coxsackie virus A9; ···●··· — Coxsackie virus B5. Horizontal scale — 10-8—10-2 — ten-fold serial dilutions of viral stocks used for the infections. Vero — control cell line that is sensitive to all four types of viruses used
Fig. 2. Tumorigenicity-inhibition assay with glioblastoma neurosheres pretreated with each f the four viruses before being injected subcutaneously into nude mice. Bars reflect number of tumors formed in each treated and untereated (Contr) group of mice. PVS1 — Type 1 Poliovirus; CV-A7 — Coxsackie virus A7; CV-A9 — Coxsackie virus A9; CV-B5 — Coxsackie virus B5